Menu
Congressional Budget Office logo
Spending on pharmaceuticals in the 340B drug discount program went from nearly $7 billion in 2010 to $44 billion by 2021—a 19% annual increase—according to preliminary Congressional Budget Office estimates released this week.

CBO Analysts Say Drug Spending Through 340B Grew 19% Annually From 2010 to 2021, 340B Champion Points Finger at Drug Industry

Shannon Young, Managing Editor 340B Report Views
Spending on pharmaceuticals in the 340B drug discount program went from nearly $7 billion in 2010 to $44 billion by [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

GAO Reissues Recommendations to Improve 340B Compliance, Medicare Financial Stability

Senate Companion Bill Introduced to Expand 340B Eligibility to Certain Rural, Outpatient Hospitals

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live